KWAG
BIIB icon

Kiely Wealth Advisory Group’s Biogen BIIB Stock Holding History

Kiely Wealth Advisory Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$35.2K Hold
247
– – 0.02% 131
2024
Q3 		$41.5K Hold
247
– – 0.03% 124
2024
Q2 		$50K Hold
247
– – 0.03% 107
2024
Q1 		$53.5K Hold
247
– – 0.03% 100
2023
Q4 		$60.6K Buy
+247
New +$60.7K 0.04% 90

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kiely Wealth Advisory Group's BIIB Position: Q4 2024 in Review

Kiely Wealth Advisory Group held its Biogen (BIIB) position steady in Q4 2024 at 247 shares worth $35.2K. The position accounts for 0.02% of the portfolio, ranked #131.

Kiely Wealth Advisory Group first reported a position in BIIB in Q4 2023 and has held it in 5 quarters since. The position peaked at $60.6K in Q4 2023. 874 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Kiely Wealth Advisory Group held 247 shares of Biogen worth $35.2K as of Q4 2024.
  • Kiely Wealth Advisory Group left its Biogen share count unchanged in Q4 2024.
  • Biogen made up 0.02% of Kiely Wealth Advisory Group's portfolio in Q4 2024, its #131 holding.
  • Kiely Wealth Advisory Group first reported a position in Biogen in Q4 2023 and has held it in 5 quarters since.
  • Kiely Wealth Advisory Group's Biogen position peaked at $60.6K in Q4 2023.
  • 874 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Kiely Wealth Advisory Group's 13F filing for Q4 2024, filed 12 Feb 2025.